Kenneth Kleinhenz is currently the Chief Operating Officer at Lorem Cytori USA, a device-based, adipose-focused stem cell company. Mr. Kleinhenz was a principal member of the Lorem Cytori USA acquisition team that purchased Cytori Therapeutics in 2019. Previously, Mr. Kleinhenz was the Vice President of Quality and Regulatory at Avelas Biosciences, Vice President of Global Regulatory Affairs and Quality Assurance at Cytori Therapeutics, Director of Regulatory Affairs at MacroPore Biosurgery, Chief Microbiologist for Becton Dickinson, and the Manager of Quality Assurance and Regulatory Affairs at Pacific Pharmaceuticals. Mr. Kleinhenz is a veteran of the United States Navy where he served as a Clinical Microbiologist for 6 years at the Naval Hospital, San Diego. Mr. Kleinhenz received his BS in Microbiology at the University of California, San Diego (UCSD) and his MBA in Technology Management at the University of Phoenix.
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948